Last reviewed · How we verify

NCT03411993

Prevalence of Rheumatic Heart Disease Among Pregnant Women in Kenya

Completed Last updated 27 July 2018
What this trial tests

trial testing Focused cardiac echography in Cardiac Disease in 612 participants. Completed in 12 March 2018.

Timeline
31 January 2018
Primary endpoint
12 March 2018
12 March 2018

Quick facts

Lead sponsorMoi University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment612
Start date31 January 2018
Primary completion12 March 2018
Estimated completion12 March 2018
Sites1 location across Kenya

Drugs / interventions tested

Conditions studied

Sponsor

Moi University

Who can join

Adults 18 to 45, female only, with Cardiac Disease or Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is currently no routine screening for cardiac disease for pregnant women in areas of high prevalence. This study will aim to determine the point prevalence of cardiac disease in women presenting for antenatal care at Moi Teaching and Referral Hospital. More specifically, it will aim to use focused echocardiography as a screening tool to determine the prevalence of cardiac disease among pregnant women attending MTRH antenatal clinic.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cardiac Disease

Currently open trials in the same condition.

Other Moi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03411993.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing